Endocrine Society Part of Coalition That Developed New Osteoporosis, Fracture Treatment Guidelines

The Endocrine Society recently participated in a coalition of bone health experts, physicians, specialists, and patient advocacy groups to develop clinical care recommendations for the treatment of osteoporosis and resulting hip and spine fractures.

The Secondary Fracture Prevention: Consensus Recommendations from a Multistakeholder Coalition was published online in the peer-reviewed Journal of Bone and Mineral Research.

These recommendations outline the best course of clinical care for women and men, ages 65 years or older, with a hip or vertebral fracture, and emphasize that fracture patients should be managed in a multi-disciplinary clinical system to ensure appropriate evaluation and treatment for osteoporosis and risk of future fractures.

You may also like

  • Artificial Intelligence Improves X-ray Identification of Patients with Broken Bones

    Artificial intelligence that can “read” electronic radiology reports and flag patients with broken bones who are at risk of osteoporosis outperformed the traditional manual method of health care professionals reading X-ray reports, a new study finds. The results were presented during a virtual news conference hosted by the Endocrine Society. The new search tool, called…

  • Endocrine Society Updates Osteoporosis Clinical Practice Guideline

    New recommendations include romosozumab therapy for high risk patients The Endocrine Society today announced an update to its osteoporosis Clinical Practice Guideline to include recommendations for romosozumab, a new medication that was approved last year to treat postmenopausal women at high risk of fracture. The U.S. Food and Drug Administration approved romosozumab in April 2019,…

Find more in